Cargando…

Predicting Outcome in an Intensive Outpatient PTSD Treatment Program Using Daily Measures

It is useful to investigate factors that could predict treatment outcomes for PTSD. The current study aims to investigate the relationship between daily measured PTSD symptoms during an intensive six-day treatment program and overall post-treatment outcomes. The treatment program combines eye moveme...

Descripción completa

Detalles Bibliográficos
Autores principales: Alting van Geusau, Valentijn V. P., Mulder, Jeroen D., Matthijssen, Suzy J. M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468454/
https://www.ncbi.nlm.nih.gov/pubmed/34575263
http://dx.doi.org/10.3390/jcm10184152
_version_ 1784573674161963008
author Alting van Geusau, Valentijn V. P.
Mulder, Jeroen D.
Matthijssen, Suzy J. M. A.
author_facet Alting van Geusau, Valentijn V. P.
Mulder, Jeroen D.
Matthijssen, Suzy J. M. A.
author_sort Alting van Geusau, Valentijn V. P.
collection PubMed
description It is useful to investigate factors that could predict treatment outcomes for PTSD. The current study aims to investigate the relationship between daily measured PTSD symptoms during an intensive six-day treatment program and overall post-treatment outcomes. The treatment program combines eye movement desensitization with reprocessing and prolonged exposure, as well as physical activity and psychoeducation. It was expected that for the entire duration of treatment, as well as the first half of the treatment, a greater decline in daily PTSD symptoms would be a predictor for a greater decline in PTSD symptoms at a four-week follow-up. Data from 109 PTSD-patients (87.2% female, mean age = 36.9, SD = 11.5) were used. PTSD symptoms were measured with the CAPS-5 and the self-reported PTSD checklist for DSM-5 (PCL-5). Daily PTSD symptoms were measured with an abbreviated version of the PCL-5 (8-item PCL). Latent growth curve models were used to describe changes in daily PTSD symptoms and predict treatment outcome. Results show that a greater decline in daily PTSD symptoms measured by the 8-item PCL predicts better treatment outcome (CAPS-5 and PCL-5), but that a patient’s PTSD symptoms on the first day of treatment has no predictive effect. A decline in PTSD symptoms only during the first half of treatment was also found to predict treatment outcomes. Future research should be focused on replicating the results of the current study.
format Online
Article
Text
id pubmed-8468454
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84684542021-09-27 Predicting Outcome in an Intensive Outpatient PTSD Treatment Program Using Daily Measures Alting van Geusau, Valentijn V. P. Mulder, Jeroen D. Matthijssen, Suzy J. M. A. J Clin Med Article It is useful to investigate factors that could predict treatment outcomes for PTSD. The current study aims to investigate the relationship between daily measured PTSD symptoms during an intensive six-day treatment program and overall post-treatment outcomes. The treatment program combines eye movement desensitization with reprocessing and prolonged exposure, as well as physical activity and psychoeducation. It was expected that for the entire duration of treatment, as well as the first half of the treatment, a greater decline in daily PTSD symptoms would be a predictor for a greater decline in PTSD symptoms at a four-week follow-up. Data from 109 PTSD-patients (87.2% female, mean age = 36.9, SD = 11.5) were used. PTSD symptoms were measured with the CAPS-5 and the self-reported PTSD checklist for DSM-5 (PCL-5). Daily PTSD symptoms were measured with an abbreviated version of the PCL-5 (8-item PCL). Latent growth curve models were used to describe changes in daily PTSD symptoms and predict treatment outcome. Results show that a greater decline in daily PTSD symptoms measured by the 8-item PCL predicts better treatment outcome (CAPS-5 and PCL-5), but that a patient’s PTSD symptoms on the first day of treatment has no predictive effect. A decline in PTSD symptoms only during the first half of treatment was also found to predict treatment outcomes. Future research should be focused on replicating the results of the current study. MDPI 2021-09-15 /pmc/articles/PMC8468454/ /pubmed/34575263 http://dx.doi.org/10.3390/jcm10184152 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alting van Geusau, Valentijn V. P.
Mulder, Jeroen D.
Matthijssen, Suzy J. M. A.
Predicting Outcome in an Intensive Outpatient PTSD Treatment Program Using Daily Measures
title Predicting Outcome in an Intensive Outpatient PTSD Treatment Program Using Daily Measures
title_full Predicting Outcome in an Intensive Outpatient PTSD Treatment Program Using Daily Measures
title_fullStr Predicting Outcome in an Intensive Outpatient PTSD Treatment Program Using Daily Measures
title_full_unstemmed Predicting Outcome in an Intensive Outpatient PTSD Treatment Program Using Daily Measures
title_short Predicting Outcome in an Intensive Outpatient PTSD Treatment Program Using Daily Measures
title_sort predicting outcome in an intensive outpatient ptsd treatment program using daily measures
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468454/
https://www.ncbi.nlm.nih.gov/pubmed/34575263
http://dx.doi.org/10.3390/jcm10184152
work_keys_str_mv AT altingvangeusauvalentijnvp predictingoutcomeinanintensiveoutpatientptsdtreatmentprogramusingdailymeasures
AT mulderjeroend predictingoutcomeinanintensiveoutpatientptsdtreatmentprogramusingdailymeasures
AT matthijssensuzyjma predictingoutcomeinanintensiveoutpatientptsdtreatmentprogramusingdailymeasures